Home Law \ Legal Kirkland Advises GTCR on Strategic Majority Investment in Biocoat

Kirkland Advises GTCR on Strategic Majority Investment in Biocoat

1 min read
Comments Off on Kirkland Advises GTCR on Strategic Majority Investment in Biocoat
0
25


Kirkland & Ellis advised GTCR on its strategic, majority investment in Biocoat Holdings, LLC (Biocoat), a leading medical device contract manufacturing organization. As part of its Leaders Strategy™ to find and partner with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions, GTCR will partner with industry veteran Chip Hance, the current Chairman of GTCR portfolio company Regatta Medical Holdings, LLC (d/b/a Resonetics), who will join Biocoat as Executive Chairman. Going forward, the existing Biocoat management team, led by CEO Jim Moran, will continue in their existing roles executing on Biocoat’s growth initiatives in partnership with GTCR.





Source link

Load More Related Articles
Load More By 
Load More In Law \ Legal
Comments are closed.

Check Also

Russell Investments Canada Launches Tax-Managed Investment Solutions for Canadian Investors

Article content Financial advisors and investors across Canada can now access innovative s…